Clinical Reviewers To CDER: Give Us PRO Training
A repository of patient-reported outcomes instruments and dedicated PRO experts in each review division also could help boost the use of such data in drug labeling, FDA reviewers said.
A repository of patient-reported outcomes instruments and dedicated PRO experts in each review division also could help boost the use of such data in drug labeling, FDA reviewers said.